Skip to Content
Merck
All Photos(1)

Documents

C2162700

Ciclopirox olamine

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolammonium salt

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C12H17NO2 · C2H7NO
CAS Number:
41621-49-2
Molecular Weight:
268.35
MDL number:
MFCD00078997
UNSPSC Code:
41116107
PubChem Substance ID:
329774970
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

ciclopirox

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

NCCO.CC1=CC(=O)N(O)C(=C1)C2CCCCC2

InChI

1S/C12H17NO2.C2H7NO/c1-9-7-11(13(15)12(14)8-9)10-5-3-2-4-6-10;3-1-2-4/h7-8,10,15H,2-6H2,1H3;4H,1-3H2

InChI key

MBRHNTMUYWQHMR-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Ciclopirox olamine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

Product No.
Description
Pricing

C2162702

Ciclopirox impurity B, European Pharmacopoeia (EP) Reference Standard

C2162701

Ciclopirox impurity A, European Pharmacopoeia (EP) Reference Standard

Y0000040

Ciclopirox, European Pharmacopoeia (EP) Reference Standard

1134030

Ciclopirox olamine, United States Pharmacopeia (USP) Reference Standard

1134040

Ciclopirox Related Compound B, United States Pharmacopeia (USP) Reference Standard

1134018

Ciclopirox, United States Pharmacopeia (USP) Reference Standard

1134084

Ciclopirox Related Compound C, United States Pharmacopeia (USP) Reference Standard

1134029

Ciclopirox Related Compound A, United States Pharmacopeia (USP) Reference Standard

PHR1920

Ciclopirox, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2854

Ciclopirox Related Compound B, certified reference material, pharmaceutical secondary standard

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H315 - H319 - H335

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 2

1 of 2

≥98% (HPLC), solid

Sigma-Aldrich

B6938

Bisdemethoxycurcumin

≥92.5% (TLC), powder

Sigma-Aldrich

D9533

Deferoxamine mesylate salt

Young Kim et al.
In vivo (Athens, Greece), 25(6), 887-893 (2011-10-25)
Aberrant activation of Wnt/β-catenin signaling promotes the development of several types of cancer. Recently, it has been demonstrated that Wnt pathway is also activated in myeloma. Therefore, the Wnt/β-catenin signaling molecules are attractive candidates for development of targeted therapies for
Luis Nogueiras-Nieto et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 83(3), 370-377 (2012-12-04)
This work investigated the use of in situ gelling hydrogels based on polypseudorotaxanes of Pluronic F-127 and partially methylated β-cyclodextrin as aqueous nail lacquers. N-acetylcysteine and urea were incorporated as penetration enhancers. The formulations were tested for their ability to
Ciclopirox olamine: a hydroxypyridone antifungal agent.
B B Abrams et al.
Clinics in dermatology, 9(4), 471-477 (1991-10-01)
Fernanda Simas Corrêa Biancalana et al.
Mycopathologia, 172(4), 279-285 (2011-05-26)
Reference methods for antifungal susceptibility tests recommend the use of conidia as inoculum. However, some isolates produce few conidia, while the invasive form of filamentous fungi in general is hyphae making susceptibility tests infeaseble. These facts suggest that other than
D Monti et al.
The British journal of dermatology, 165(1), 99-105 (2011-03-18)
Topical therapy has recently been proposed for treating onychomycosis and other nail disturbances. However, the clinical outcome may be limited by the difficulty of active ingredients effectively penetrating the nail plate. Bovine hoof membranes have been widely used to predict
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service